{{Rsnum
|rsid=11064768
|Gene=CCDC60
|Chromosome=12
|position=119380704
|Orientation=plus
|GMAF=0.03535
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=CCDC60
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 80.5 | 16.8 | 2.7
| HCB | 100.0 | 0.0 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 100.0 | 0.0 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 100.0 | 0.0 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 80.2 | 18.8 | 1.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 89.7 | 10.3 | 0.0
| MKK | 94.9 | 5.1 | 0.0
| TSI | 84.3 | 15.7 | 0.0
| HapMapRevision=28
}}

{{GWAS Summary
|SNP=rs11064768
|PubMedID=18332876
|Condition=Schizophrenia
|Gene=CCDC60
|Risk Allele=A
|pValue=1.00E-006
|OR=NA
|95CI=
}}

{{PharmGKB
|RSID=rs11064768
|Name_s=
|Gene_s=CCDC60
|Feature=
|Evidence=PubMed ID:18332876; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS Results: A genome-wide association study in 574 schizophrenia trios using DNA pooling (Initial Sample Size: 574 cases, 605 controls, 1,148 parents of cases; Replication Sample Size: NR; Risk Allele: rs11064768-A).
|Drugs=
|Drug Classes=
|Diseases=Schizophrenia
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356760
}}

{{PMID Auto
|PMID=20485477
|Title=New Genetic Findings in Schizophrenia: Is there Still Room for the Dopamine Hypothesis of Schizophrenia?
|OA=1
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs11064768
|overall_frequency_n=3
|overall_frequency_d=128
|overall_frequency=0.0234375
|n_genomes=2
|n_genomes_annotated=0
|n_haplomes=2
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}